SCHEMBL102903

SCHEMBL102903

N#CC1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1513767 0.97
SCHEMBL25040502 0.89
Propane SCHEMBL28276647 0.89 KCNH2 (0.32)
SCHEMBL25040974 0.89
SCHEMBL30917712 0.89
SCHEMBL25040506 0.89
Hydrochloric Acid SCHEMBL25287231 0.87 CXCR4 (0.30)
Hydrochloric Acid SCHEMBL31385112 0.87 CXCR4 (0.30)
SCHEMBL20156438 0.84
Hydrochloric Acid SCHEMBL8824346 0.83 SLC18A3 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2503 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036681-A Synthesis method of fluoxastrobin sulfonate intermediate 江苏省农用激素工程技术研究中心有限公司 2026-05-15 CN claimed
US-20260109697-A1 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2026-04-23 US claimed
US-20250353862-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2025-11-20 US claimed
US-12448389-B2 BRM targeting compounds and associated methods of use PRELUDE THERAPEUTICS INCORPORATED (US) 2025-10-21 US claimed
EP-4615523-A1 COMPOUNDS AND THEIR USE KING'S COLLEGE LONDON (GB) 2025-09-17 EP claimed
WO-2025149628-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE ASTRAZENECA AB (SE) 2025-07-17 WO claimed
CN-120117949-A Method for directly preparing tertiary amine compound from aromatic aldehyde, ketone and secondary amine 湖南大学 2025-06-10 CN claimed
EP-4547671-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2025-05-07 EP claimed
EP-4013755-B1 PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS NOVARTIS AG (CH) 2025-01-08 EP claimed
CN-119255997-A Modulators of c-MYC mRNA translation and their use in the treatment of cancer 艾尼莫生物科技公司 2025-01-03 CN claimed
US-7348435-B2 Process for producing cyanopiperidine JUBILANT ORGANOSYS LIMITED (IN) 2008-03-25 US claimed
US-20060084808-A1 Process for producing cyanopiperidine JUBILANT ORGANOSYS LIMITED (IN) 2006-04-20 US claimed
US-5126455-A Preparation of substituted alkali metal piperidine-4-carboxylates GLAXO INC. (US) 1992-06-30 US claimed
US-5039804-A Hydrolysis of 1,3,8,-triazaspiro 4.5!decane-2,4-diones, chemical intermediates for opium type analgesics GLAXO INC. (US) 1991-08-13 US claimed
EP-0213337-B1 4-CYANOPIPERIDINE DERIVATIVES, PREPARATION AND USE THEREOF Eisai Co., Ltd. (JP) 1991-05-15 EP claimed
US-4925901-A STORAGE STAABILITY, ONIUM ION CATALYST THE DOW CHEMICAL COMPANY (US) 1990-05-15 US claimed
EP-0188805-B1 1,3-DITHIOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-09-06 EP claimed
US-4721788-A 4-cyanopiperidine derivatives EISAI CO., LTD. (JP) 1988-01-26 US claimed
EP-0213337-A1 4-cyanopiperidine derivatives, preparation and use thereof Eisai Co., Ltd. (JP) 1987-03-11 EP claimed
EP-0188805-A1 1,3-Dithiole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1986-07-30 EP claimed